Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Help me out here. Why would the correspondence address and e-mail be updated to the old Tustin location that is vacant. Also we know Aiura resigned. Why do they continue to go thru the trouble to play this apparent charade- to buy time or something more?

Why can't they reveal themselves at this late stage already? Obviously they are still trying to keep the patent filing alive, but what benefit do they gain like this?

Still confused as to what is going on.